We are live on ! Find out more
MEDP icon

Medpace

729 hedge funds and large institutions have $11.5B invested in Medpace in 2026 Q1 according to their latest regulatory filings, with 86 funds opening new positions, 237 increasing their positions, 298 reducing their positions, and 132 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.52% more ownership

Funds ownership: 84.39%84.9% (+0.52%)

7% less funds holding

Funds holding: 785729 (-56)

14% less capital invested

Capital invested by funds: $13.4B → $11.5B (-$1.81B)

20% less repeat investments, than reductions

Existing positions increased: 237 | Existing positions reduced: 298

33% less funds holding in top 10

Funds holding in top 10: 96 (-3)

35% less first-time investments, than exits

New positions opened: 86 | Existing positions closed: 132

41% less call options, than puts

Call options by funds: $13.6M | Put options by funds: $23.2M

Holders
729
Holders Change
-56
Holders Change %
-7.13%
% of All Funds
8.97%
Holding in Top 10
6
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-33.33%
% of All Funds
0.07%
New
86
Increased
237
Reduced
298
Closed
132
Calls
$13.6M
Puts
$23.2M
Net Calls
-$9.55M
Net Calls Change
+$27.3M

MEDP Hedge Fund Activity: Q1 2026 in Review

729 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q1 2026, worth a combined $11.5B — down 14% from $13.4B a quarter earlier.

Sellers outnumbered buyers: 132 funds closed out of MEDP and 86 opened new positions — a net loss of 46 holders — while 298 trimmed existing stakes and 237 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $88.5M. The largest seller was Findlay Park Partners, exiting entirely with an estimated $98M sold.

  • 729 institutional investors held Medpace (MEDP) as of Q1 2026, down from 785 in Q4 2025.
  • Funds reported $11.5B of Medpace stock for Q1 2026, down 14% quarter-over-quarter.
  • 86 funds opened new Medpace positions in Q1 2026 and 132 closed out, a net change of -46 holders.
  • The largest Medpace buyer in Q1 2026 was T. Rowe Price Associates, an estimated $88.5M added.
  • The largest Medpace seller in Q1 2026 was Findlay Park Partners, an estimated $98M sold.

Based on aggregated 13F filings for Q1 2026.